@article{article, title = {{Long-term efficacy and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis : results through week 52 from a phase III open-label extension trial (LIBERTY AD PED-OLE)}}, publisher = {{Springer Nature}}, url = {{}}, year = {{2022}}, month = {{5}}, author = {{Blauvelt A and Guttman-Yassky E and Paller AS and Simpson EL and Cork MJ and Weisman J and Browning J and Soong W and Sun X and Chen Z and Kosloski MP et al}}, doi = {{10.1007/s40257-022-00683-2}}, volume = {{23}}, journal = {{American Journal of Clinical Dermatology}}, issue = {{3}}, pages = {{365-383}}, note = {{Accessed on 2025/04/11}}}